Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC314554PMC
http://dx.doi.org/10.1136/bmj.328.7432.167-cDOI Listing

Publication Analysis

Top Keywords

timing simvastatin
4
simvastatin treatment
4
treatment strong
4
strong change
4
change practice
4
timing
1
treatment
1
strong
1
change
1
practice
1

Similar Publications

Statins for the primary prevention of venous thromboembolism.

Cochrane Database Syst Rev

November 2024

Department of Breast Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.

Background: Venous thromboembolism (VTE) involves the formation of a blood clot in a vein, and includes deep venous thrombosis (DVT) or pulmonary embolism (PE). The annual incidence for VTE varies from 0.75 to 2.

View Article and Find Full Text PDF

Background: The increasing prevalence of statin use for cardiovascular disease management has raised concerns regarding their safety profile, particularly regarding the potential risk of diabetes. Our study aims to analyze diabetic adverse event reports related to statins using a large pharmacovigilance database to provide timely insights into this significant issue.

Methods: We analyzed data from the FDA Adverse Event Reporting System (FAERS) database from 2004 to 2023.

View Article and Find Full Text PDF

Effect of DHCR7 for the co-occurrence of hypercholesterolemia and vitamin D deficiency in type 2 diabetes: Perspective of health prevention.

Prev Med

August 2023

Department of Endocrinology, First Affiliated Hospital of Harbin Medical University, Harbin, China; Department of Endocrinology, Southern University of Science and Technology Hospital, Shenzhen, China. Electronic address:

Type 2 diabetes mellitus (T2DM) is a complex disease caused by multiple factors, which are often accompanied by the disorder of glucose and lipid metabolism and the lack of vitamin D.Over the years, researchers have conducted numerous studies into the pathogenesis and prevention strategies of diabetes. In this study, diabetic SD rats were randomly divided into type 2 diabetes group, vitamin D intervention group, 7-dehydrocholesterole reductase (DHCR7) inhibitor intervention group, simvastatin intervention group, and naive control group.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!